newsfilter
← Latest News
Business Wire·

Imago BioSciences Announces Its Addition to the Russell 2000® Index

​Imago BioSciences, Inc. (Imago) (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced that it will be added to the Russell® 2000 Index as part of